Decreased expression of lncRNA ANRIL suppressed cell proliferation, migration, and invasion when the PI3K/AKT pathway was inactivated, suggesting that ANRIL inhibits cervical cancer progression via the PI3K/AKT pathway. This evidence concerns the gene CDKN2B-AS1 and cervical carcinoma.